Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.87 is 85% above its 5-year average of -12.34, near the high end of its 5-year range (-39.60–-1.87).
57.79% above its 12-month average of -4.43.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-06-30): -0.80.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.87
EARNINGS PER SHARE (EPS) AVG TTM
-4.43
EARNINGS PER SHARE (EPS) AVG 3Y
-5.52
EARNINGS PER SHARE (EPS) AVG 5Y
-12.34
EARNINGS PER SHARE (EPS) AVG 10Y
-167.61
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+57.79%
CURRENT VS 3Y AVG
+66.14%
CURRENT VS 5Y AVG
+84.84%
CURRENT VS 10Y AVG
+98.88%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Outlook Therapeutics, Inc.
Market Cap
$108.05M
Earnings Per Share (EPS)
-1.87
TTM Avg
-4.43
3Y Avg
-5.52
5Y Avg
-12.34
Market Cap
$108.18M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.33
3Y Avg
-0.37
5Y Avg
-0.32
Market Cap
$107.06M
Earnings Per Share (EPS)
-4.80
TTM Avg
-8.13
3Y Avg
-18.81
5Y Avg
-23.77
Market Cap
$108.98M
Earnings Per Share (EPS)
-3.21
TTM Avg
-1.79
3Y Avg
-1.14
5Y Avg
-1.14
Market Cap
$106.61M
Earnings Per Share (EPS)
-6.48
TTM Avg
-4.79
3Y Avg
-7.51
5Y Avg
-13.98
Market Cap
$108.66M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.43
3Y Avg
-0.38
5Y Avg
-0.36
Market Cap
$109.91M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.47
3Y Avg
-0.54
5Y Avg
-0.49
Market Cap
$105.20M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.42
3Y Avg
-1.68
5Y Avg
-1.45
Market Cap
$104.18M
Earnings Per Share (EPS)
-0.12
TTM Avg
-0.17
3Y Avg
-0.12
5Y Avg
-0.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $108.05M | -1.87 | -4.43 | -5.52 | -12.34 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.18M | -0.71 | -0.33 | -0.37 | -0.32 |
| Immunic, Inc. (IMUX)vs › | $107.06M | -4.80 | -8.13 | -18.81 | -23.77 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.98M | -3.21 | -1.79 | -1.14 | -1.14 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.61M | -6.48 | -4.79 | -7.51 | -13.98 |
| Vivani Medical, Inc. (VANI)vs › | $108.66M | -0.35 | -0.43 | -0.38 | -0.36 |
| Apyx Medical Corporation (APYX)vs › | $109.91M | -0.21 | -0.47 | -0.54 | -0.49 |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | -1.60 | -2.42 | -1.68 | -1.45 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | -0.12 | -0.17 | -0.12 | -0.12 |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.45M | -0.30 | -0.36 | -0.38 | -0.40 |
Trailing EPS (TTM)
$-1.87
Forward EPS (Est.)
$-0.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-09-30 | -4.06 |
| 2023-09-30 | -4.80 |
| 2022-09-30 | -6.23 |
| 2021-09-30 | -7.00 |
| 2019-09-30 | -39.60 |
| 2018-09-30 | -194.80 |
| 2017-09-30 | -267.20 |
| 2016-09-30 | -587.20 |
| 2015-09-30 | -564.14 |
| 2014-09-30 | -1.05 |
